Detailed price information for Caris Life Sciences Inc (CAI-Q) from The Globe and Mail including charting and trades.
Introducing a new RNA-seq platform for intracellular multimodal profiling that could transform cancer research and ...
The Caris Lookback Program identified 13,293 patients potentially eligible for newly approved targeted therapies across 10 ...
GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms ...
Spatial-biology tools are collecting more comprehensive data, and companies that want to model cells in silico are hoovering ...
Researchers develop IRISeq and EnrichSci to map cellular neighborhoods and analyze rare aging cells in the brain simultaneously.
Genomics provides advanced tools for single cell and spatial biology research, serving academic and biopharma institutions ...
Researchers have introduced a novel diagnostics method that can more sensitively detect gene fusions in B-cell acute ...
Researchers have introduced a novel diagnostic method that can more sensitively detect gene fusions in B-cell acute ...
Researchers have introduced a novel diagnostics method that can more sensitively detect gene fusions in B-cell acute ...
Caris Life Sciences, Inc. (Nasdaq: CAI), a leading, patient centric, next-generation AI TechBio company and precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results